<DOC>
	<DOCNO>NCT00300768</DOCNO>
	<brief_summary>The primary purpose study determine safety tolerability moxidectin subject infect O. volvulus special emphasis Mazzotti reaction determine whether safe enough expose number subject sufficient obtain statistically significant data safety efficacy moxidectin relative ivermectin . Secondary object determine pharmacokinetics moxidectin , obtain initial indication efficacy term long term effect skin microfilaria level indication effect macrofilaria may underlie effect skin microfilaria level .</brief_summary>
	<brief_title>Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection</brief_title>
	<detailed_description />
	<mesh_term>Onchocerciasis</mesh_term>
	<mesh_term>Intestinal Volvulus</mesh_term>
	<mesh_term>Milbemycin</mesh_term>
	<mesh_term>Ivermectin</mesh_term>
	<criteria>1 . Written , sign ( thumbprinted ) , date informed consent 2 . Aged 18 60 year , inclusive 3 . Body weight ≥ 40 kg woman ≥ 45 kg men 4 . Nonpregnant , nonbreastfeeding woman . Women child bear potential must agree use birth control first 150 day treatment . 5 . Healthy , determine physician basis physical examination , ECG , thorough review medical history clinical laboratory result 6 . Adequate hematologic , renal , hepatic function 7 . Skin microfilarial density within require range cohort 1 . Participation study purely observational one , within 4 week test article administration . 2 . Any vaccination within 4 week test article administration 3 . Acute infection require therapy within last 10 day test article administration 4 . Administration medication ( exception medication require treat reaction screen fluorescein angiography ( chlorpheniramine ) paracetamol ) herbal preparation within 10 day prior test article administration condition currently require regular medication 5 . Clinically significant ECG abnormality history cardiac abnormality 6 . Past current history neurological neuropsychiatric disease epilepsy 7 . Subjects orthostatic hypotension screen evaluation 8 . History drug alcohol abuse regular use ≥ 3 cigarette per day 9 . Use alcohol drug abuse within 72 hour test article administration 10 . Any condition , investigator 's opinion , place subject undue risk 11 . Subjects donate blood within 8 week study entry 12 . Subjects ocular onchocerciasis cohort intend enroll subject mild infection . Ocular onchocerciasis define presence live dead microfilariae , onchocercal punctate opacity , onchocercal lesion posterior segment lesion mimic see onchocerciasis . 13 . Subjects hyperreactive onchodermatitis 14 . Antifilarial therapy within previous 5 year 15 . Coincidental infection Loa Loa 16 . Female subject childbearing potential contraindication DMPA Norplant 17 . Any condition investigator feel would exclude subject study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>onchocerciasis</keyword>
	<keyword>onchocerca volvulus</keyword>
	<keyword>river blindness</keyword>
	<keyword>ivermectin</keyword>
	<keyword>moxidectin</keyword>
</DOC>